Sabatine, M. S., Giugliano, R. P., Keech, A., Honarpour, N., Wang, H., Liu, T., . . . Pedersen, T. R. (2016). Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial. The American heart journal, 173, 94-101. https://doi.org/10.1016/j.ahj.2015.11.015
Citace podle Chicago (17th ed.)Sabatine, Marc S., et al. "Rationale and Design of the Further Cardiovascular OUtcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk Trial." The American Heart Journal 173 (2016): 94-101. https://doi.org/10.1016/j.ahj.2015.11.015.
Citace podle MLA (9th ed.)Sabatine, Marc S., et al. "Rationale and Design of the Further Cardiovascular OUtcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk Trial." The American Heart Journal, vol. 173, 2016, pp. 94-101, https://doi.org/10.1016/j.ahj.2015.11.015.